Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients

Summary

Excluding or confirming pulmonary embolism remains a diagnostic challenge. In elderly patients pulmonary embolism is associated with substantial co-morbidity and mortality, and many elderly patients with suspected pulmonary embolism are inpatients. The safety and efficacy of the combination of a clinical probability (CDR) and d-dimer test in excluding pulmonary embolism in this group is unclear. We retrospectively analysed data of two prospective studies of consecutive in-and outpatients with suspected pulmonary embolism. The patients were categorized into three age groups: <65 years, 65–75 years and >75 years. The sensitivity, negative predictive value and the proportion of patients with the combination of a non-high CDR score according to Wells (≤ 4) and a normal d-dimer result were calculated for each group. In 747 consecutive patients with suspected pulmonary embolism, sensitivity and negative predictive value of a non-high CDR and a normal d-dimer result in outpatients (n=538) of all age categories (<65 years, 65–75 years and >75 years) were both 100%.These tests were, however, less reliable for inpatients(n=209), irrespective of their age (sensitivity 91% [ CI: 79–98%], negative predictive value 88 % [CI: 74–96%].The proportion of both in-and outpatients >75 years with a non-high CDR and a normal d-dimer concentration was only 14%,whereas this was 22% in patients 65–75 years and 41% among in-and outpatients <65 years, respectively. In elderly outpatients the combination of a non-high CDR and a normal d-dimer result is a safe strategy to rule out pulmonary embolism. However, in inpatients this algorithm is not reliable to safely exclude pulmonary embolism. In addition, the proportion of patients >65 years in which this strategy excludes pulmonary embolism is markedly lower compared to younger patients.

Keywords

Pulmonary embolism - CDR - D-dimer - elderly

^* The authors have no relevant financial interest in this article.

• References

• 1 Buller HR, Agnelli G, Hull RD. et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; Oct 126 (Suppl. 03) 401S-28S.
• 2 Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 18 (Suppl. 01) 1309-12.
• 3 Levine MN, Raskob G, Beyth RJ. et al. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; Oct 126 (Suppl. 03) 287S-310S.
• 4 Palareti G, Leali N, Coccheri S. et al. Bleeding complications of oral anticoagulant treatment: an inception- cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; Aug 17 348 (9025) 423-8.
• 5 Righini M, Goehring C, Bounameaux H. et al. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000; Oct 1 109 (05) 357-61.
• 6 Ceccarelli E, Masotti L, Barabesi L. et al. Pulmonary embolism in very old patients. Aging Clin Exp Res 2003; May 15 (02) 117-22.
• 7 Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000; Nov 1 109 (05) 357-61.
• 8 Wells PS, Anderson DR, Rodger M. et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 2001; Jul 17 135 (02) 98-107.
• 9 Kruip MJ, Slob MJ, Schijen JH. et al. Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Arch Intern Med 2002; Jul 22 162 (14) 1631-5.
• 10 Ten Wolde M, Hagen PJ, Macgillavry MR. et al. Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study. J Thromb Haemost 2004; Jul 2 (07) 1110-7.
• 11 Kruip MJ, Leclercq MG, van der HC. et al. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med 2003; Jul 17 138 (12) 941-51.
• 12 Wells PS, Anderson DR, Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; Mar 83 (03) 416-20.
• 13 Mari D, Mannucci PM, Coppola R. et al. Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995; Jul 1 85 (11) 3144-9.
• 14 Hager K, Platt D. Fibrin degeneration product concentrations (D-dimers) in the course of ageing. Gerontology 1995; 41 (03) 159-65.
• 15 Pieper CF, Rao KM, Currie MS. et al. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 2000; Nov 55 (11) M649-M657.
• 16 Becker DM, Philbrick JT, Bachhuber TL. et al. D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis?. Arch Intern Med 1996; May 13 156 (09) 939-46.
• 17 Raimondi P, Bongard O, de Moerloose P. et al. D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res 1993; Jan 1 69 (01) 125-30.
• 18 Siddique RM, Siddique MI, Connors Jr. AF. et al. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med 1996; Dec 11 156 (20) 2343-7.
• 19 Righini M, de Moerloose P, Reber G. et al. Should the D-dimer cut-off value be increased in elderly patients suspected of pulmonary embolism?. Thromb Haemost 2001; 85 (04) 744.